Dave Mullarkey is the founder of Omniome. Omniome has raised $160M in total funding. Latest round: Series C. Based in San Diego, United States.
Dave Mullarkey is the Co-founder and former CEO of Omniome, a San Diego-based DNA sequencing startup that developed a proprietary short-read genomic sequencing platform. Omniome was acquired by Pacific Biosciences (PacBio) in 2021 in a deal worth up to approximately $800 million, after which Mullarkey exited the company. He is currently the CEO of ClearNote Health, an early cancer detection company based in Menlo Park, California.
Full founder directory · Investor directory · Company funding database · Fundraising library